far
two
type
coronaviru
surfac
receptor
group
ii
coronaviru
mous
hepat
viru
mhv
use
murin
carcinoembryon
antigenrel
cell
adhes
molecul
ceacam
member
immunoglobulin
superfamili
number
group
coronavirus
exampl
human
coronaviru
transmiss
gastroenter
viru
felin
infecti
periton
viru
requir
zinc
metalloproteas
aminopeptidas
n
apn
entri
target
recent
distinct
coronaviru
identifi
aetiolog
agent
sar
acut
pulmonari
syndrom
character
atyp
pneumonia
result
progress
respiratori
failur
death
close
analysi
sarscov
genom
suggest
viru
belong
three
defin
coronaviru
group
sarscov
protein
similarli
similar
analog
human
immunodefici
viru
hiv
influenza
protein
protein
mhv
group
iii
coronaviru
infecti
bronchiti
cleav
two
subunit
cellular
proteas
virusproduc
protein
coronavirus
includ
group
probabl
sarscov
cleav
virusproduc
nonetheless
domain
latter
protein
identifi
homolog
subunit
cleav
coronaviru
protein
domain
character
coronavirus
mediat
initi
highaffin
associ
respect
african
green
monkey
kidney
cell
line
vero
permit
replic
first
investig
whether
domain
sarscov
protein
could
bind
vero
cell
figur
demonstr
protein
express
residu
sarscov
protein
fuse
fc
domain
human
specif
recogn
moieti
present
vero
cell
bind
human
kidney
cell
use
fusion
protein
fig
carboxi
termin
tag
form
domain
fig
protein
band
approxim
kda
could
immunoprecipit
metabol
label
vero
cell
lyse
phosphatebuff
salin
immunoprecipit
protein
incub
pngase
f
enzym
remov
nglycosyl
two
band
observ
approxim
kda
fig
lane
analys
kda
band
trypsin
digest
mass
spectrometri
three
human
protein
identifi
whose
sequenc
consist
mass
tryptic
fragment
obtain
band
two
protein
myosin
major
vault
protein
local
cell
surfac
ubiquit
express
therefor
analys
eight
independ
tryptic
fragment
consist
sequenc
compris
amino
acid
sequenc
human
also
identifi
supplementari
inform
tissu
distribut
subcellular
local
appropri
receptor
clone
complementari
dna
obtain
human
lung
analysi
cell
transfect
plasmid
express
transfect
vector
alon
specif
recogn
fig
solubl
form
relat
enzym
block
associ
vero
cell
fig
furthermor
immunoprecipit
solubl
form
fig
lane
recogn
antibodi
lane
approxim
kda
solubl
form
incub
pngase
f
kda
band
observ
fig
lane
indic
lower
band
observ
pngaseftr
vero
immunoprecipit
fig
lane
data
demonstr
specif
highaffin
associ
domain
sarscov
protein
protein
mediat
fusion
viral
cellular
membran
case
also
cell
express
viral
fusion
protein
express
viral
receptor
instanc
cell
express
envelop
glycoprotein
form
multinucl
syncytia
cell
express
receptor
ref
syncytia
observ
vero
cultur
infect
sarscov
sarscovinfect
primat
sar
investig
whether
cell
express
sarscov
protein
could
fuse
cell
express
figur
show
cell
form
syncytia
effici
expect
cell
transfect
form
mani
syncytia
cell
express
top
left
cell
express
sarscov
protein
bottom
left
contrast
cell
express
form
syncytia
cell
express
top
right
form
mani
larg
syncytia
cell
express
protein
bottom
right
cell
express
protein
also
effici
form
syncytia
mocktransfect
hela
cell
shown
syncytia
format
protein
cell
block
affinitypurifi
antibodi
rais
control
antibodi
fig
data
demonstr
abil
sarscov
protein
mediat
fusion
depend
presenc
investig
abil
mediat
viral
replic
mocktransfect
cell
incub
presenc
absenc
sarscov
day
cultur
numer
detach
round
float
cell
observ
cultur
infect
cell
shown
consist
viral
replic
contrast
infect
mocktransfect
cell
uninfect
cell
indistinguish
uninfect
control
cell
cell
display
none
sign
cytopath
observ
infect
cell
figur
show
mocktransfect
cell
support
effici
replic
sarscov
measur
viral
genom
rna
cell
supernat
semiquantit
polymeras
chain
reaction
revers
transcript
found
viral
genom
copi
cell
increas
first
h
fig
bottom
panel
contrast
genom
copi
mocktransfect
cell
increas
tenfold
period
top
panel
indic
basal
replic
cell
addit
viru
titr
supernat
infect
mocktransfect
cell
measur
titrat
onto
vero
cell
shown
fig
viru
stock
obtain
h
infect
cell
effici
replic
vero
cell
visibl
cytopath
effect
cpe
includ
highest
dilut
assay
wherea
viru
stock
obtain
mocktransfect
cell
induc
cpe
beyond
dilut
consist
basal
replic
observ
infect
assay
minor
express
cell
subsequ
detect
antibodi
supplementari
inform
also
investig
abil
antibodi
inhibit
viral
replic
vero
cell
antibodi
observ
effect
viral
induc
cytopath
wherea
antibodi
inhibit
cytopath
dosedepend
manner
fig
collect
data
show
contribut
substanti
effici
sarscov
replic
show
immunoprecipit
vero
cell
domain
sarscov
protein
mediat
fusion
sproteinexpress
cell
promot
viral
replic
cell
line
otherwis
ineffici
sarscov
infect
moreov
syncytia
format
viral
replic
specif
inhibit
antibodi
data
demonstr
function
receptor
sarscov
realtim
pcr
analysi
human
tissu
demonstr
effici
express
messeng
rna
bronchu
lung
parenchyma
well
heart
kidney
gastrointestin
lung
kidney
also
primari
site
express
murin
ref
tissu
distribut
consist
patholog
sar
character
acut
infect
sarscov
also
found
kidney
tissu
infect
replic
effici
primat
kidney
cell
line
vero
ref
activ
viral
replic
small
larg
intestin
detect
viru
may
reflect
express
messag
physiolog
role
tissu
defin
although
thought
essenti
regul
cardiac
candid
substrat
regul
vasoperm
unclear
whether
sarscov
interfer
enzymat
activ
manner
contribut
pathogenesi
sar
receptor
number
coronavirus
like
zinc
metalloproteas
howev
apart
common
two
receptor
wide
diverg
may
suggest
properti
class
proteas
contribut
viral
replic
howev
mutat
catalyt
site
interfer
tissuecultur
replic
transmiss
gastroenter
viru
use
enzym
similarli
preliminari
studi
show
syncytia
format
mediat
sarscov
protein
remain
effici
two
activesit
histidin
modifi
asparagin
supplementari
inform
number
antibodi
peptid
small
compound
shown
bind
ref
possibl
may
use
treatment
sar
either
block
sproteinbind
site
induc
conform
unfavour
bind
fusion
altern
solubl
form
receptor
may
slow
viral
replic
infect
individu
identif
sarscov
receptor
facilit
descript
receptorbind
domain
protein
presum
effect
target
epitop
subunit
vaccin
also
like
cell
line
approv
vaccin
product
made
permiss
viral
replic
express
effici
largescal
produc
wholekil
attenu
viru
use
vaccin
mous
transgen
human
may
use
anim
model
sar
final
studi
interact
sarscov
protein
anim
may
provid
insight
origin
viru
thu
sar
return
threat
human
health
studi
may
contribut
control
vero
cell
metabol
label
h
cystein
methionin
lyse
ml
per
dish
ddm
anatrac
phosphatebuff
salin
pb
contain
proteaseinhibitor
cocktail
sigma
roch
mm
phenylmethylsulphonyl
fluorid
sigma
remov
cell
debri
centrifug
lysat
incub
h
room
temperatur
purifi
human
receptor
fusion
construct
protein
sepharos
altern
ctermin
form
domain
control
protein
incub
antibodi
nation
cell
cultur
center
togeth
protein
sepharos
precipit
wash
twice
ddmpb
pb
alon
bound
protein
elut
reduc
laemmli
sampl
buffer
nonreduc
buffer
min
protein
separ
gel
electrophoresi
page
trisglycin
gel
invitrogen
use
approach
approxim
unlabel
vero
cell
use
gener
distinct
band
kda
could
readili
visual
coomassi
stain
band
excis
gel
incub
trypsin
mass
tryptic
fragment
determin
matrixassist
laser
desorpt
ioniz
timeofflight
mass
spectrometri
mass
compar
possibl
tryptic
fragment
protein
genbank
databas
use
sequest
softwar
plasmid
encod
signal
sequenc
fusion
domain
sarscov
protein
residu
first
residu
domain
fc
region
human
respect
transfect
cell
immunoglobulin
fusion
protein
purifi
protein
sepharos
bead
total
cell
transfect
control
plasmid
number
untransfect
vero
cell
incub
volum
case
solubl
form
r
system
also
includ
cell
wash
pb
bsa
incub
fitclabel
goat
antihuman
igg
fc
sigma
analys
flow
cytometri
cell
approxim
confluent
sixwel
plate
transfect
calciumphosph
method
plasmid
encod
codonoptim
form
sarscov
protein
envelop
glycoprotein
ada
isol
parallel
hela
cell
transfect
plasmid
encod
receptor
one
day
transfect
cell
trypsin
express
viralenvelop
protein
mix
cell
express
receptor
ratio
plate
plate
h
mix
multinucl
giant
cell
observ
case
goat
antibodi
goat
antibodi
r
system
ad
time
cell
mix
sarscov
urbani
strain
provid
l
anderson
center
diseas
control
prevent
passag
vero
cell
cell
transfect
flask
alon
express
infect
h
tissuecultur
infecti
dose
sarscov
measur
endpoint
titrat
vero
cell
left
uninfect
wash
twice
cultur
medium
cell
monitor
cytopath
effect
day
aliquot
cell
supernat
collect
h
wash
rna
recov
use
viral
rna
miniprep
kit
qiagen
semiquantit
perform
use
nest
protocol
describ
ref
posit
control
rna
provid
c
drosten
bernhard
nocht
institut
tropic
medicin
nation
refer
center
tropic
diseas
viru
titrat
perform
seed
vero
cell
per
well
microtitr
plate
day
infect
cultur
supernat
infect
cell
ad
first
set
well
triplic
serial
dilut
cell
monitor
cpe
day
infect
vero
cell
effect
affinitypurifi
goat
antibodi
sarscovinduc
cytopath
measur
read
absorb
nm
cell
incub
celltit
promega
